COWAN ELVIA (SVP, Finance & CAO) sold 44.4% of their position (11.62K shares) of VAXCYTE, INC. on the open market
Open‑market sale worth $557.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/29/2025ACC: 0001960048-25-000010
Officer· SVP, Finance & CAO
Since Feb 2026
-12.62K
Net shares
Net seller
$557.0K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
12.62K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−4.91K
Price / share
$47.90
Trade value
$235.04K
% of position
18.8%
12/23/2025
26.16K→21.25K
Common Stock
Direct
Shares
−6.72K
Price / share
$47.94
Trade value
$321.93K
% of position
31.6%
12/23/2025
21.25K→14.53K
Common Stock
Direct
Shares
−1K
Price / share
—
Trade value
—
% of position
6.9%
12/23/2025
14.53K→13.53K
Total
Net shares
−12.62K
Net value
-$556.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2025 | S · Sale | −4.91K | $47.90 | $235.04K | 18.8% | 26.16K | 21.25K |
| Common Stock Direct | 12/23/2025 | S · Sale | −6.72K | $47.94 | $321.93K | 31.6% | 21.25K | 14.53K |
| Common Stock Direct | 12/23/2025 | G · Gift | −1K | — | — | 6.9% | 14.53K | 13.53K |
| Total | −12.62K | -$556.97K | ||||||
Derivative Transactions0
No derivative transactions reported